Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 111801-111850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03287193
Identification of the Molecular And/or Pathophysiological Bases of Developmental Diseases
N/ARecruiting
850 participants
Started: Mar 13, 2017 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03096418
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
PHASE4Recruiting
50 participants
Started: Mar 13, 2017 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT03419260
Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children
N/ARecruiting
2,500 participants
Started: Mar 13, 2017 · Completed: Jan 1, 2027
1 condition2 sponsors1 location
NCT03049462
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists
PHASE1Recruiting
100 participants
Started: Mar 13, 2017 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT04439227
Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)
PHASE2Active, not recruiting
35 participants
Started: Mar 13, 2017 · Completed: Dec 31, 2026
6 conditions1 sponsor1 location
NCT03134742
Radiation Effects on Bone
N/AEnrolling by invitation
50 participants
Started: Mar 13, 2017 · Completed: Apr 13, 2025
1 condition1 sponsor1 location
NCT06385496
Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With mTOR Genetic Changes (MATCH - Subprotocol L)
PHASE2Active, not recruiting
35 participants
Started: Mar 12, 2017 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT06390865
Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)
PHASE2Active, not recruiting
49 participants
Started: Mar 12, 2017 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT06390852
Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)
PHASE2Active, not recruiting
35 participants
Started: Mar 12, 2017 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT03560999
Non-Anesthetized Plexus Technique for Infant (BPBP) MRI Evaluation
N/AActive, not recruiting
100 participants
Started: Mar 11, 2017 · Completed: Dec 31, 2024
3 conditions1 sponsor3 locations
NCT03072927
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
N/ARecruiting
8,000 participants
Started: Mar 10, 2017 · Completed: Dec 31, 2026
1 condition1 sponsor2087 locations
NCT03093961
REDUCE LAP-HFREF TRIAL
NAActive, not recruiting
10 participants
Started: Mar 10, 2017 · Completed: Dec 31, 2027
1 condition1 sponsor4 locations
NCT05945576
IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
N/ARecruiting
2,000 participants
Started: Mar 10, 2017 · Completed: Mar 31, 2028
9 conditions1 sponsor20 locations
NCT02544308
Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma
PHASE3Active, not recruiting
36 participants
Started: Mar 10, 2017 · Completed: Dec 31, 2026
1 condition3 sponsors13 locations
NCT03039712
Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers
N/AActive, not recruiting
37,000 participants
Started: Mar 10, 2017 · Completed: Jun 30, 2029
1 condition1 sponsor1 location
NCT06855355
CBM588 Reduces Colorectal Polyp Recurrence
NAEnrolling by invitation
500 participants
Started: Mar 10, 2017 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT02983461
Use of Sildenafil for Treatment of Urinary Incontinence
PHASE1Active, not recruiting
24 participants
Started: Mar 10, 2017 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT03064646
Organ Preservation in Locally Advanced Rectal Cancer
NARecruiting
30 participants
Started: Mar 10, 2017 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT02989636
Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma
PHASE1Active, not recruiting
21 participants
Started: Mar 10, 2017 · Completed: Nov 30, 2026
1 condition4 sponsors2 locations
NCT04001023
Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia
NARecruiting
40 participants
Started: Mar 9, 2017 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT03080948
Risk Stratification Among Individuals Who Have Many Moles on Their Skin
N/AActive, not recruiting
73 participants
Started: Mar 9, 2017 · Completed: Mar 31, 2026
1 condition4 sponsors4 locations
NCT02920788
Mild TBI Assessment & Rehabilitation
NARecruiting
65 participants
Started: Mar 9, 2017 · Completed: Apr 30, 2026
1 condition1 sponsor2 locations
NCT03054896
A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome
PHASE2Active, not recruiting
69 participants
Started: Mar 8, 2017 · Completed: Dec 1, 2027
1 condition2 sponsors3 locations
NCT03011814
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
PHASE1/PHASE2Active, not recruiting
38 participants
Started: Mar 8, 2017 · Completed: Aug 30, 2026
8 conditions2 sponsors4 locations
NCT03089203
CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer
PHASE1Active, not recruiting
23 participants
Started: Mar 8, 2017 · Completed: Dec 8, 2038
1 condition1 sponsor1 location
NCT03220373
Predicting Dropout and Outcome From Neuropsychological Functions in SUD Patients
N/AActive, not recruiting
200 participants
Started: Mar 7, 2017 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT02978118
Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)
N/AActive, not recruiting
67 participants
Started: Mar 7, 2017 · Completed: Oct 31, 2028
2 conditions2 sponsors1 location
NCT02998268
Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
PHASE2Active, not recruiting
42 participants
Started: Mar 7, 2017 · Completed: Sep 30, 2026
1 condition2 sponsors4 locations
NCT03023540
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
PHASE3Active, not recruiting
187 participants
Started: Mar 7, 2017 · Completed: Dec 31, 2024
1 condition7 sponsors23 locations
NCT03093116
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
PHASE1/PHASE2Recruiting
500 participants
Started: Mar 7, 2017 · Completed: Feb 29, 2028
2 conditions2 sponsors165 locations
NCT02812420
Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery
EARLY_PHASE1Active, not recruiting
54 participants
Started: Mar 7, 2017 · Completed: Dec 31, 2027
19 conditions2 sponsors1 location
NCT03012399
Hypnosedation in Relaxing Patients Undergoing Breast Cancer Surgery
NAActive, not recruiting
50 participants
Started: Mar 7, 2017 · Completed: Apr 30, 2027
8 conditions2 sponsors1 location
NCT02886065
A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM
PHASE1Active, not recruiting
19 participants
Started: Mar 7, 2017 · Completed: Sep 15, 2026
1 condition3 sponsors6 locations
NCT03036488
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)
PHASE3Active, not recruiting
1,174 participants
Started: Mar 7, 2017 · Completed: Oct 14, 2025
1 condition1 sponsor193 locations
NCT02960087
Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
NAActive, not recruiting
334 participants
Started: Mar 6, 2017 · Completed: Oct 30, 2029
1 condition1 sponsor7 locations
NCT03009981
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
PHASE3Active, not recruiting
504 participants
Started: Mar 6, 2017 · Completed: Jan 1, 2026
1 condition2 sponsors69 locations
NCT03073083
Graft Selection in Anatomic Anterior Cruciate Ligament Reconstruction
NARecruiting
439 participants
Started: Mar 6, 2017 · Completed: Dec 31, 2029
1 condition3 sponsors2 locations
NCT06715917
Multicentre GMK UNI Anatomical Cementless Study - FR
N/AActive, not recruiting
249 participants
Started: Mar 6, 2017 · Completed: Mar 6, 2032
3 conditions1 sponsor5 locations
NCT04204837
Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin
PHASE2Recruiting
61 participants
Started: Mar 6, 2017 · Completed: Dec 31, 2027
1 condition2 sponsors7 locations
NCT04007783
Validation of the O-bridge Protocol: a Prospective, Multicenter Trial
N/ARecruiting
80 participants
Started: Mar 4, 2017 · Completed: Dec 31, 2027
5 conditions1 sponsor5 locations
NCT02864004
Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)
PHASE3Active, not recruiting
134 participants
Started: Mar 3, 2017 · Completed: Jan 30, 2025
1 condition1 sponsor20 locations
NCT03074513
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
PHASE2Active, not recruiting
133 participants
Started: Mar 3, 2017 · Completed: Sep 30, 2027
21 conditions2 sponsors1 location
NCT03289949
The Neurobiological Effect of 5-HT2AR Modulation
PHASE1Recruiting
200 participants
Started: Mar 3, 2017 · Completed: Jun 1, 2030
1 condition1 sponsor1 location
NCT03020030
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
PHASE3Active, not recruiting
560 participants
Started: Mar 3, 2017 · Completed: Nov 30, 2034
1 condition2 sponsors9 locations
NCT03069378
A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
PHASE2Active, not recruiting
41 participants
Started: Mar 3, 2017 · Completed: Mar 31, 2026
3 conditions3 sponsors5 locations
NCT02983578
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer
PHASE2Active, not recruiting
39 participants
Started: Mar 2, 2017 · Completed: Aug 30, 2025
25 conditions3 sponsors1 location
NCT03055871
Parents and Children Active Together Study
NARecruiting
240 participants
Started: Mar 1, 2017 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT03781531
Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism
N/ARecruiting
1,000 participants
Started: Mar 1, 2017 · Completed: Dec 31, 2028
2 conditions2 sponsors2 locations
NCT06893731
Healthcare Utilization and Economic Burden of Cardiomyopathy in China
N/AEnrolling by invitation
10,000 participants
Started: Mar 1, 2017 · Completed: Apr 1, 2026
2 conditions1 sponsor1 location
NCT03117036
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
N/ARecruiting
600 participants
Started: Mar 1, 2017 · Completed: Dec 28, 2026
2 conditions2 sponsors1 location